X0202 SCHEDULE 13G 0001218710 XXXXXXXX LIVE Common Stock, par value $0.01 per share 03/31/2026 0002029039 Nasus Pharma Ltd IL001218553 29 Harakevet Street Tel Aviv L3 6618003 Rule 13d-1(b) Balyasny Asset Management L.P. DE 1169910 0 1169910 0 1169910 N 9.99 IA PN BAM GP LLC DE 1169910 0 1169910 0 1169910 N 9.99 HC OO Balyasny Asset Management Holdings LP DE 1169910 0 1169910 0 1169910 N 9.99 HC PN Dames GP LLC DE 1169910 0 1169910 0 1169910 N 9.99 HC OO Dmitry Balyasny X1 1169910 0 1169910 0 1169910 N 9.99 HC IN Nasus Pharma Ltd 29 Harakevet Street, Tel Aviv, Israel 6618003 This statement is being filed by (1) Balyasny Asset Management L.P., a Delaware limited partnership ("BAM"), (2) BAM GP LLC, a Delaware limited liability company ("BAM GP"), (3) Balyasny Asset Management Holdings LP, a Delaware limited partnership ("BAM Holdings"), (4) Dames GP LLC, a Delaware limited liability company ("Dames"), and (5) Dmitry Balyasny, a United States citizen (collectively, the "Reporting Persons"). BAM GP is the General Partner of BAM. BAM Holdings is the Sole Member of BAM GP. Dames is the General Partner of BAM Holdings. Dmitry Balyasny is the Managing Member of Dames. The principal business address of each of BAM, BAM GP, BAM Holdings, Dames, and Mr. Balyasny is located at 444 West Lake Street, 50th Floor, Chicago, IL 60606. (1) BAM is a Delaware limited partnership, (2) BAM GP is a Delaware limited liability company, (3) BAM Holdings is a Delaware limited partnership, (4) Dames is a Delaware limited liability company, and (5) Mr. Balyasny is a United States citizen. N IA HC By virtue of its position as the investment manager of Atlas Private Holdings (Cayman) Ltd. ("APHC"), the direct holder of the 1,169,910 shares of common stock (including 271,437 shares issuance upon exercise of warrants), par value $0.01 per share, reported herein, BAM may be deemed to exercise voting and investment power over such Shares held by APHC and thus may be deemed to beneficially own such Shares. By virtue of its position as the General Partner of BAM, BAM GP may be deemed to exercise voting and investment power over the Shares held directly by APHC and thus may be deemed to beneficially own such Shares. By virtue of its position as the Sole Member of BAM GP, BAM Holdings may be deemed to exercise voting and investment power over the Shares held directly by APHC and thus may be deemed to beneficially own such Shares. By virtue of its position as the General Partner of BAM Holdings, Dames may be deemed to exercise voting and investment power over the Shares held directly by APHC and thus may be deemed to beneficially own such Shares. By virtue of his position as the Managing Member of Dames, Mr. Balyasny may be deemed to exercise voting and investment power over the Shares held directly by APHC and thus may be deemed to beneficially own such Shares. Each of the Reporting Persons may be deemed to be the beneficial owner of approximately 9.99% of the Shares, based on 11,710,808 Shares outstanding as of March 27, 2026, as reported in the Issuer's post-effective amendment to its registration statement on form F-1 filed with the Securities and Exchange Commission on March 27, 2026. The report amount consists of 898,473 shares and 271,437 shares issuable upon the exercise of 898,473 Warrants subject to the Beneficial Ownership Limitation (as defined herein). The Warrants are subject to a blocker which prevents the holder from exercising the Warrants to the extent that, upon such exercise, the holder would beneficially own in excess of 9.99% of the Shares outstanding as a result of the exercise (the "Beneficial Ownership Limitation"). Each of the Reporting Persons has the sole power to vote or to direct the vote of 1,169,910 shares. 0 Each of the Reporting Persons has the sole power to vote or to direct the vote of 1,169,910 shares. 0 Y N APHC, a Cayman Islands exempted company that is an investment management client of BAM, has the right to receive dividends from, or the proceeds from the sale of, the reported securities. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Balyasny Asset Management L.P. /s/ Scott Schroeder 05/11/2026 BAM GP LLC /s/ Scott Schroeder 05/11/2026 Balyasny Asset Management Holdings LP /s/ Scott Schroeder 05/11/2026 Dames GP LLC /s/ Scott Schroeder 05/11/2026 Dmitry Balyasny /s/ Dmitry Balyasny 05/11/2026